CDSCO UID IMP/MD/2023/000784_808cac49a1507ae5ebb18fc8f803e969_140386096d67c55f446a0ece6b9d1a4eBreast Biopsy Probe
- UID
- IMP/MD/2023/000784_808cac49a1507ae5ebb18fc8f803e969_140386096d67c55f446a0ece6b9d1a4e
- Device class
- Class B
- Brand name
- EnCor® Breast Biopsy Probes
- License holder
- Becton Dickinson India Private Limited
- Approving authority
- CDSCO
- Product information
- The EnCor® Breast Biopsy Probe and MRI breast probes are indicated to acquire tissue for diagnostic sampling of breast abnormalities. The instrument is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of histologic abnormality cannot be reliably determined from its mammographic or imaged appearance. Therefore, the extent of removal of the imaged evidence of an abnormality does not predict the extent of removal of a histologic abnormality, e.g., malignancy. When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures
Breast Biopsy Probe is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2023/000784_808cac49a1507ae5ebb18fc8f803e969_140386096d67c55f446a0ece6b9d1a4e. This device is marketed under the brand name EnCor® Breast Biopsy Probes. The license holder is Becton Dickinson India Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.